Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna K Sanoff

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|June 6, 2022
Improving Treatment Approaches for Rectal CancerHanna K Sanoff
JAMA Oncology|July 24, 2020
Managing Grief, Loss, and Connection in Oncology-What COVID-19 Has TakenHanna K Sanoff
The Lancet. Oncology|March 28, 2017
Targeting HER2 beyond progression in gastroesophageal cancerHanna K Sanoff
JAMA|May 26, 2018
Best Evidence Supports Annual Surveillance for Resected Colorectal CancerHanna K Sanoff
JCO Oncology Practice|September 19, 2024
Putting IDEA's Results Into Practice: Practicality Should Rule Complexity in Stage III Colon CancerHanna K Sanoff
Cancer Cell|August 30, 2024
PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancerAshwin Somasundaram, Hanna K Sanoff
BMJ (Clinical Research Ed.)|December 8, 2020
Cancer of unknown primaryMichael S Lee, Hanna K Sanoff
Gastrointestinal Cancer Research : GCR|March 6, 2009
Colorectal cancer treatment in older patientsHanna K Sanoff, Richard M Goldberg
Seminars in Colon & Rectal Surgery|December 4, 2009
Predictive Factors for Response and Toxicity in Chemotherapy: PharmacogenomicsHanna K Sanoff, Howard L McLeod
Current Treatment Options in Oncology|March 18, 2024
Social Determinants of Health and the Link to Colorectal Cancer OutcomesMichael K Lorentsen, Hanna K Sanoff
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|June 6, 2022
Improving Treatment Approaches for Rectal CancerHanna K Sanoff
JAMA Oncology|July 24, 2020
Managing Grief, Loss, and Connection in Oncology-What COVID-19 Has TakenHanna K Sanoff
The Lancet. Oncology|March 28, 2017
Targeting HER2 beyond progression in gastroesophageal cancerHanna K Sanoff
JAMA|May 26, 2018
Best Evidence Supports Annual Surveillance for Resected Colorectal CancerHanna K Sanoff
JCO Oncology Practice|September 19, 2024
Putting IDEA's Results Into Practice: Practicality Should Rule Complexity in Stage III Colon CancerHanna K Sanoff
Cancer Cell|August 30, 2024
PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancerAshwin Somasundaram, Hanna K Sanoff
BMJ (Clinical Research Ed.)|December 8, 2020
Cancer of unknown primaryMichael S Lee, Hanna K Sanoff
Gastrointestinal Cancer Research : GCR|March 6, 2009
Colorectal cancer treatment in older patientsHanna K Sanoff, Richard M Goldberg
Seminars in Colon & Rectal Surgery|December 4, 2009
Predictive Factors for Response and Toxicity in Chemotherapy: PharmacogenomicsHanna K Sanoff, Howard L McLeod
Current Treatment Options in Oncology|March 18, 2024
Social Determinants of Health and the Link to Colorectal Cancer OutcomesMichael K Lorentsen, Hanna K Sanoff
Pageof 13